Our capital, experience, network and infrastructure in China allow us to provide the resources and support to our portfolio companies for conducting R&D, clinical trials in top-tier Chinese hospitals, making successful regulatory submissions, commercialization and manufacturing in this dynamic market.

We focus on innovation in the Biotech and MedTech fields that can best address China’s long-term development of its healthcare systems. Since 2016 we show a consistent track record of applying our unique investment model. To date we have established numerous JV companies in China in partnership with world-renowned foreign companies.

Moreover, our associated Guangzhou Sino-Israel Bio-industry Incubator (BIG) has allowed us to cater to start-ups, entrepreneurs and scientists developing cutting-edge technologies suited to the Chinese market. Under our multinational incubator program, we invest and support local and international companies in R&D and company formation.